LYTIX BIOPHARMA ASA

Lytix Biopharma ASA: Grant of share options to management and key personnel

Oslo, Norway – 23 July 2026 – Lytix Biopharma ASA (the “Company”) announces that the Board of Directors has approved the grant of 1,230,400 share options under the Company’s long-term incentive program. Key terms of the grants • Each option gives the holder the right to acquire one share in the Com...